🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🆕🗞️Published today JCO Precision Oncology ASCO The1️⃣st AGNOSTIC study of a PARP⛔️inhibitor: 📚LODESTAR: Rucaparib💊 🎯Need to think about variants in Homologous Recombination Repair (HRR) Genes 🧬 beyond canonical #BRCA #PALB2. 💡Novel insights. OncoAlert 🔗ascopubs.org/doi/10.1200/PO…

Cancer leaves deep emotional scars long after treatment ends, but for many survivors, honest, unfiltered writing can be a powerful path to healing. Learn more from William Ramshaw, Let's Win Patient Advisory Board Member. Via CURE Today. curetoday.com/view/writing-h…

🔬New GI cancer CE/CME available! Learn about evolving treatment strategies for PDAC w/ Mike Pishvaian and explore Advances in Biomarker Testing and Treatment in mCRC w/ Aparna Raj Parikh! 🔗Access the courses here! tinyurl.com/vbzhn5dd tinyurl.com/3cjsac6t #oncology #gotoPER

Pathology-oriented multiplexing enables integrative disease mapping nature.com/articles/s4158… PathoPlex is a highly multiplexed imaging at subcellular resolution with a software package (spatiomic) to interpret protein co-expression patterns (clusters) across biological layers.

Fascinating & important Cell paper from Helmholtz Munich | @HelmholtzMunich Functional liver genomics identifies hepatokines promoting wasting in cancer cachexia cell.com/cell/fulltext/… A study that links deregulation of the hepatic circadian clock with peripheral tissue wasting.

Stop! Please stop everything you are doing right now and read below super-important message from ECOG-ACRIN chairs- Drs. O’Dwyer and Schnall! If we lose public support for pivotal NCI coop group research and it needs to stop- resuscitating it will be very hard or impossible…

What should I eat while in treatment? Oncology dietitian Maria Petzel provides eating strategies for pancreatic cancer patients. bit.ly/42rW28C

Sharon had a BRCA mutation but didn't know it linked to pancreatic cancer. After surgery, her cancer researcher brother helped develop a new treatment—she was the first to try it. 13 years later, that drug inspired the SHARON trial. bit.ly/4kTt2ho

4.1K likes & 169K views on this post...which fails to mention the patient was also receiving standard of care 1st line "big pharma" FOLFIRINOX chemotherapy (info buried in screenshotted email)🤦🏽‍♀️.

#PancreaticCancer science day at MD Anderson Cancer Center 💕 the personalized touch!

What can you expect during pancreatic cancer diagnostic testing? Dr. Gobind Anand offers expert guidance to stay informed throughout the process. bit.ly/3vRqmwH

Challenges associated with screening the general (average risk) population for #PancreaticCancer. And why enrichment is absolutely pivotal. Enrichment to higher risk populations raises the positive predictive value (PPV) of any biomarker assay performed. Via Johannes Fahrmann

Launched today- the Weill Cancer Hub West -supporting transformative cancer research collaborations btw UC San Francisco & Stanford University. Honored to co-lead, with Long Lab, our team who will study the impact of diet on pancreatic cancer initiation, progression and therapy response.

New iScience journal paper by Dr. Nina Steele PascaLab Primary and metastatic cellular landscapes in human #PancreaticCancer cell.com/iscience/fullt… Signatures of pancreatic cancer metastases associated T cells (exhausted), macrophages (complement pathway) and fibroblasts (UPP1 +).

Cancer Research Communications Adding to long standing thread on single cell RNA sequencing papers in #PancreaticCancer, an important atlas by Dr. Nina Steele PascaLab: Human Pancreatic Cancer Single-Cell Atlas Reveals Association of CXCL10+Fibroblasts and Basal Subtype Tumor Cells aacrjournals.org/clincancerres/…

In 3 prospective cohorts comprised of 2.2 million individuals from UK and China, #Diabetes increases the risk of #LiverCancer #PancreaticCancer #BladderCancer New JNCI study: academic.oup.com/jnci/advance-a…

Two B2B preclinical papers published in Cancer Research - one by Channing Der Der Lab at UNC & the other by Kathleen Mulvaney - combining MTA-cooperative PRMT5 inhibitors with KRAS inhibitors in MTAP-deleted cancers. Coming to the clinic soon! aacrjournals.org/cancerres/arti… aacrjournals.org/cancerres/arti…

Correction - in the clinic already! One example below: biospace.com/press-releases… Exciting that MTAP null #PancreaticCancer might finally have a meaningful chance of being targeted.

Signed out my last #GIPath biopsy at MD Anderson Cancer Center. What a surreal feeling after 12 years. 🔬 Thank you to all my colleagues to whom I reached out for consultations. Signing out biopsies at a cancer center requires a distinct mindset than in a “general” academic setting. 😅

Excited to be attending #PancreasFest25 in Pittsburgh to speak abt the increasingly important topic of #EarlyOnset #PancreaticCancer #pancsm, & honored to be included in a wonderful roster of pancreatologists & disease experts Sylvester Comprehensive Cancer Center Miller Medicine PanCAN Let's Win Pancreatic Cancer 💜